[HTML][HTML] A FAIR-Decide framework for pharmaceutical R&D: FAIR data cost–benefit assessment
Highlights•Implementing FAIR in pharmaceutical R&D is a costly and challenging
endeavour.•None of the existing approaches for implementing FAIR principles in drug R&D …
endeavour.•None of the existing approaches for implementing FAIR principles in drug R&D …
[HTML][HTML] FAIR data management: what does it mean for drug discovery?
Y Gadiya, V Ioannidis, D Henderson… - Frontiers in Drug …, 2023 - frontiersin.org
The drug discovery community faces high costs in bringing safe and effective medicines to
market, in part due to the rising volume and complexity of data which must be generated …
market, in part due to the rising volume and complexity of data which must be generated …
FAIR data policies can benefit biotech startups
K Hardy, S Heyse - Nature Biotechnology, 2023 - nature.com
To the life science startup on a fast-paced road to delivering new therapies or devices, data
are arguably its most important asset. Establishing FAIR (findable, accessible, interoperable …
are arguably its most important asset. Establishing FAIR (findable, accessible, interoperable …
[HTML][HTML] Learning from conect4children: A Collaborative Approach towards Standardisation of Disease-Specific Paediatric Research Data
The conect4children (c4c) initiative was established to facilitate the development of new
drugs and other therapies for paediatric patients. It is widely recognised that there are not …
drugs and other therapies for paediatric patients. It is widely recognised that there are not …
Digital Evolution: Novo Nordisk's Shift to Ontology-Based Data Management
Biomedical data is growing exponentially, and managing it is increasingly challenging.
While Findable, Accessible, Interoperable and Reusable (FAIR) data principles provide …
While Findable, Accessible, Interoperable and Reusable (FAIR) data principles provide …
[HTML][HTML] POLAR Star: A New Framework Developed and Applied by One Mid-Sized Pharmaceutical Company to Drive Digital Transformation in R&D
R Mariani, MC De Vuono, E Businaro, S Ivaldi… - Pharmaceutical …, 2024 - Springer
Digital transformation has become a cornerstone of innovation in pharmaceutical research
and development (R&D). Pharmaceutical companies now have an imperative to embrace …
and development (R&D). Pharmaceutical companies now have an imperative to embrace …
Guidelines and Standard Frameworks for Artificial Intelligence in Medicine: A Systematic Review
A growing volume of evidence marks the potential of Artificial Intelligence (AI) in medicine, in
improving diagnostic accuracy, clinical decision support, risk/event prediction, drug …
improving diagnostic accuracy, clinical decision support, risk/event prediction, drug …
The systematic assessment of completeness of public metadata accompanying omics studies
The scientific community has accumulated enormous amounts of genomic data stored in
specialized public repositories. Genomic data is easily accessible and available from public …
specialized public repositories. Genomic data is easily accessible and available from public …
From spreadsheet lab data templates to knowledge graphs: A FAIR data journey in the domain of AMR research
Y Gadiya, T Abbassi-Daloii, V Ioannidis, N Juty… - bioRxiv, 2024 - biorxiv.org
While awareness of FAIR (Findable, Accessible, Interoperable, and Reusable) principles
has expanded across diverse domains, there remains a notable absence of impactful …
has expanded across diverse domains, there remains a notable absence of impactful …
Real-Time Tracking of Misdiagnosis in Electronic Health Records for Improved Predictive Modeling
Misdiagnosis, a persistent threat in healthcare, compromises patient outcomes and hinders
effective treatment. Despite its prevalence, understanding and addressing misdiagnoses …
effective treatment. Despite its prevalence, understanding and addressing misdiagnoses …